Alteration of the cellular response to interleukin-1 beta by SV40 large T antigen in rheumatoid synovial fibroblasts

Arch Virol. 1999;144(2):317-27. doi: 10.1007/s007050050506.

Abstract

The large T antigen of SV40 (LT) has been widely used to immortalize primary cells for various studies. In this study, synovial fibroblasts of a patient from rheumatoid arthritis (RA) were transformed with LT gene to analyze the effect of SV40-mediated transformation on the production of cytokines, such as IL-6, IL-8, and GM-CSF, that are under the control of interleukin-1 beta (IL-1 beta), a physiological inducer of nuclear factor kappa B (NF-kappa B). It was noted that the basal levels of GM-CSF and IL-8 were upregulated, whereas that of IL-6 was downregulated. Moreover, the extents of induction of these cytokines in response to IL-1 beta were markedly downregulated in synovial fibroblasts transformed by LT as compared from parental cells. Although IL-1 beta could translocate NF-kappa B to the nucleus in all cells, some of the transformed cells exhibited nuclear translocation of NF-kappa B even before the stimulation with IL-1 beta, suggesting that transformation of LT resulted in the constitutive activation of NF-kappa B, either directly or indirectly. In order to examine whether LT downregulate the kappa B-dependent gene expression, we performed the transient luciferase gene expression assay. We found that cotransfection of LT did not downregulate the kappa B-dependent gene expression that was stimulated with L-1 beta. These observations suggest that the apparent inhibitory effect of LT on the IL-1-induced expression of cytokines may not be through its direct action on the NF-kappa B transactivation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, Polyomavirus Transforming / genetics
  • Antigens, Polyomavirus Transforming / physiology*
  • Arthritis, Rheumatoid / metabolism
  • Arthritis, Rheumatoid / pathology
  • Cell Line, Transformed
  • Cell Transformation, Viral*
  • Cells, Cultured
  • Cytokines / drug effects
  • Cytokines / metabolism
  • DNA, Recombinant / genetics
  • Endothelial Growth Factors / metabolism
  • Endothelial Growth Factors / pharmacology
  • Female
  • Fibroblasts / drug effects*
  • Fibroblasts / metabolism
  • Fibroblasts / virology
  • Fluorescent Antibody Technique, Indirect
  • Granulocyte-Macrophage Colony-Stimulating Factor / metabolism
  • Humans
  • Interleukin-1 / pharmacology*
  • Interleukin-6 / metabolism
  • Interleukin-8 / metabolism
  • Lymphokines / drug effects
  • Lymphokines / metabolism
  • Lymphokines / pharmacology
  • Middle Aged
  • Recombinant Proteins / pharmacology
  • Simian virus 40 / genetics*
  • Simian virus 40 / immunology
  • Synovial Membrane / cytology
  • Synovial Membrane / metabolism
  • Tumor Cells, Cultured
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors

Substances

  • Antigens, Polyomavirus Transforming
  • Cytokines
  • DNA, Recombinant
  • Endothelial Growth Factors
  • Interleukin-1
  • Interleukin-6
  • Interleukin-8
  • Lymphokines
  • Recombinant Proteins
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors
  • Granulocyte-Macrophage Colony-Stimulating Factor